10-Q Filing

SUPERNUS PHARMACEUTICALS, INC. CIK: 1356576 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0001104659-14-059912`
Period End Date	20140630
Filing Date	20140812
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	supn-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 74 Cash Flow Statement 67 Comprehensive Income 14

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	130.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	130.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.91M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	42.14M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$32.98M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.96M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$40.30M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	39.98M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	42.14M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$49.21M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	39.98M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$35.31M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$5.05M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$10.85M	USD	Point-in-time
Interest receivable	`InterestReceivableCurrent`	$483.00K	USD	Point-in-time
Interest receivable	`InterestReceivableCurrent`	$496.00K	USD	Point-in-time
Inventories	`InventoryNet`	$7.15M	USD	Point-in-time
Inventories	`InventoryNet`	$10.10M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.06M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.05M	USD	Point-in-time
Deferred financing costs, current	`DeferredFinanceCostsCurrentNet`	$202.00K	USD	Point-in-time
Deferred financing costs, current	`DeferredFinanceCostsCurrentNet`	$229.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$97.16M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$71.98M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.55M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.59M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.16M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$3.08M	USD	Point-in-time
Long term marketable securities	`MarketableSecuritiesNoncurrent`	$8.76M	USD	Point-in-time
Long term marketable securities	`MarketableSecuritiesNoncurrent`	$15.46M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$361.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$361.00K	USD	Point-in-time
Deferred financing costs, long-term	`DeferredFinanceCostsNoncurrentNet`	$713.00K	USD	Point-in-time
Deferred financing costs, long-term	`DeferredFinanceCostsNoncurrentNet`	$1.00M	USD	Point-in-time
Total assets	`Assets`	$111.00M	USD	Point-in-time
Total assets	`Assets`	$94.19M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$18.31M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$19.04M	USD	Point-in-time
Deferred product revenue, net	`DeferredProductRevenueNetCurrent`	$7.88M	USD	Point-in-time
Deferred licensing revenue	`DeferredRevenueLicensingCurrent`	$204.00K	USD	Point-in-time
Deferred licensing revenue	`DeferredRevenueLicensingCurrent`	$143.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$19.19M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$26.40M	USD	Point-in-time
Deferred licensing revenue, net of current portion	`DeferredRevenueLicensingNoncurrent`	$1.42M	USD	Point-in-time
Deferred licensing revenue, net of current portion	`DeferredRevenueLicensingNoncurrent`	$1.34M	USD	Point-in-time
Convertible notes, net of discount	`ConvertibleLongTermNotesPayable`	$34.39M	USD	Point-in-time
Convertible notes, net of discount	`ConvertibleLongTermNotesPayable`	$28.67M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$2.78M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$2.68M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$12.64M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$8.83M	USD	Point-in-time
Total liabilities	`Liabilities`	$77.53M	USD	Point-in-time
Total liabilities	`Liabilities`	$60.82M	USD	Point-in-time
Common stock, $0.001 par value, 130,000,000 shares authorized at June 30, 2014 and December 31, 2013; 42,139,463 and 39,983,437 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$42.00K	USD	Point-in-time
Common stock, $0.001 par value, 130,000,000 shares authorized at June 30, 2014 and December 31, 2013; 42,139,463 and 39,983,437 shares issued and outstanding at June 30, 2014 and December 31, 2013, respectively	`CommonStockValue`	$40.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$211.95M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$224.20M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-190.87M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-178.53M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$33.46M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$33.37M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$111.00M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$94.19M	USD	Point-in-time

Income Statement 74 line items

Line Item	Tag	Value	Unit	Period
Net product sales	`SalesRevenueNet`	$154.00K	USD	2 Qtrs
Net product sales	`SalesRevenueNet`	$36.60M	USD	2 Qtrs
Net product sales	`SalesRevenueNet`	$154.00K	USD	1 Quarter
Net product sales	`SalesRevenueNet`	$27.61M	USD	1 Quarter
Licensing revenue	`LicensesRevenue`	$274.00K	USD	2 Qtrs
Licensing revenue	`LicensesRevenue`	$2.07M	USD	1 Quarter
Licensing revenue	`LicensesRevenue`	$127.00K	USD	1 Quarter
Licensing revenue	`LicensesRevenue`	$2.15M	USD	2 Qtrs
Total revenue	`Revenues`	$38.76M	USD	2 Qtrs
Total revenue	`Revenues`	$281.00K	USD	1 Quarter
Total revenue	`Revenues`	$29.68M	USD	1 Quarter
Total revenue	`Revenues`	$428.00K	USD	2 Qtrs
Cost of product sales	`CostOfGoodsSold`	$2.15M	USD	2 Qtrs
Cost of product sales	`CostOfGoodsSold`	$4.00K	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$4.00K	USD	2 Qtrs
Cost of product sales	`CostOfGoodsSold`	$1.66M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.54M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$8.06M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$4.68M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$9.16M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$25.75M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$12.21M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$37.11M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$19.58M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$48.42M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$33.82M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$25.92M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$15.76M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-15.48M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-9.67M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$3.76M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-33.39M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$187.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$55.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$85.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$107.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.28M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.48M	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.14M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.87M	USD	2 Qtrs
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$678.00K	USD	1 Quarter
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$1.35M	USD	2 Qtrs
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$-8.54M	USD	2 Qtrs
Changes in fair value of derivative liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$-8.62M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.73M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.16M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-39.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.16M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$84.00K	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$-8.00K	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-12.38M	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-2.67M	USD	2 Qtrs
Total other expense	`NonoperatingIncomeExpense`	$-11.88M	USD	1 Quarter
Total other expense	`NonoperatingIncomeExpense`	$-554.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$3.20M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-12.34M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-45.77M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-27.36M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.89	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.08	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-1.48	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.30	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.30	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.08	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-1.48	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.89	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	42.06M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	41.60M	shares	2 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	30.90M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	30.89M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	41.60M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.89M	shares	2 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	42.37M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.90M	shares	1 Quarter

Cash Flow Statement 67 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-45.77M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-27.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-12.34M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$3.20M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-39.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.16M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.73M	USD	2 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.16M	USD	1 Quarter
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	$1.35M	USD	2 Qtrs
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	$-8.54M	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments`	$178.00K	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments`	$-1.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$460.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$326.00K	USD	2 Qtrs
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$887.00K	USD	2 Qtrs
Amortization of deferred financing costs and debt discount	`AmortizationOfFinancingCostsAndDiscounts`	$1.09M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$1.32M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$769.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$537.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.80M	USD	2 Qtrs
Interest receivable	`IncreaseDecreaseInAccruedInterestReceivableNet`	$13.00K	USD	2 Qtrs
Interest receivable	`IncreaseDecreaseInAccruedInterestReceivableNet`	$127.00K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$3.16M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$2.95M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.01M	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$918.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.34M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$730.00K	USD	2 Qtrs
Deferred product revenue, net	`IncreaseDecreaseInDeferredProductRevenueNet`	$-7.88M	USD	2 Qtrs
Deferred product revenue, net	`IncreaseDecreaseInDeferredProductRevenueNet`	$3.97M	USD	2 Qtrs
Deferred licensing revenue	`IncreaseDecreaseInDeferredLicensingRevenue`	$-133.00K	USD	2 Qtrs
Deferred licensing revenue	`IncreaseDecreaseInDeferredLicensingRevenue`	$246.00K	USD	2 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$107.00K	USD	2 Qtrs
Other non-current liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$478.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-26.04M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-32.98M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$19.90M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$61.00M	USD	2 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$24.41M	USD	2 Qtrs
Sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$27.09M	USD	2 Qtrs
Purchases of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.04M	USD	2 Qtrs
Purchases of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$381.00K	USD	2 Qtrs
Capitalized patent defense costs	`PaymentsToAcquireIntangibleAssets`	$2.04M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-37.63M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$4.77M	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.15M	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$251.00K	USD	2 Qtrs
Proceeds from convertible debt issuance	`ProceedsFromConvertibleDebt`	$90.00M	USD	2 Qtrs
Cash settlement of debt to equity conversion	`RepaymentsOfConvertibleDebt`	$1.00K	USD	2 Qtrs
Repayment of secured notes payable	`RepaymentsOfSecuredDebt`	$24.34M	USD	2 Qtrs
Financing costs and underwriters discounts	`PaymentsOfFinancingCosts`	$3.60M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$250.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$64.21M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-6.39M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-21.02M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$40.30M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.96M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$32.98M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$33.91M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$40.30M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.96M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$32.98M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$33.91M	USD	Point-in-time
Cash paid for interest	`InterestPaid`	$975.00K	USD	2 Qtrs
Cash paid for interest	`InterestPaid`	$1.50M	USD	2 Qtrs
Conversion of convertible notes	`DebtConversionConvertedInstrumentAmount1`	$10.68M	USD	2 Qtrs
Initial value of interest make-whole derivative issued in connection with the convertible debt	`StockIssued1`	$9.27M	USD	2 Qtrs

Comprehensive Income 14 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-45.77M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-27.36M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-12.34M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$3.20M	USD	1 Quarter
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$1.00K	USD	2 Qtrs
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-178.00K	USD	2 Qtrs
Unrealized net gain (loss) on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-147.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-147.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$1.00K	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-178.00K	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-27.50M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-45.95M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-12.34M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$3.20M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.